- Home
- ATXS vs SNCY Comparison
ATXS vs SNCY Comparison
Compare ATXS & SNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATXS | SNCY |
|---|---|---|
| Founded | 2008 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 732.4M | 766.5M |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ATXS | SNCY |
|---|---|---|
| Price | $13.10 | $14.39 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $24.33 | $18.57 |
| AVG Volume (30 Days) | ★ 1.2M | 733.6K |
| Earning Date | 11-12-2025 | 02-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.51 |
| EPS | N/A | ★ 1.05 |
| Revenue | $706,000.00 | ★ $1,106,213,000.00 |
| Revenue This Year | N/A | $6.16 |
| Revenue Next Year | N/A | $8.41 |
| P/E Ratio | ★ N/A | $13.71 |
| Revenue Growth | N/A | ★ 4.27 |
| 52 Week Low | $3.56 | $8.10 |
| 52 Week High | $13.29 | $18.59 |
Technical Indicators
Market Signals| Indicator | ATXS | SNCY |
|---|---|---|
| Relative Strength Index (RSI) | 65.67 | 54.33 |
| Support Level | $12.64 | $14.16 |
| Resistance Level | $13.03 | $14.65 |
| Average True Range (ATR) | 0.19 | 0.46 |
| MACD | -0.02 | -0.13 |
| Stochastic Oscillator | 94.00 | 16.12 |
Price Performance
Historical ComparisonAbout ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About SNCY Sun Country Airlines Holdings Inc.
Sun Country Airlines Holdings Inc operates low-cost air carriers. The business has two operating segments: Passenger and Cargo. The passenger segment has two internal passenger groups Scheduled service and Charter. The Cargo segment provides air cargo services. The majority of the revenue is from the passenger segment.